VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,704,394 Value ($000) $19,143 Avg Close — Range —
Q1 2025
Shares 1,682,391 Value ($000) $7,690 Avg Close — Range —
Q4 2024
Shares 1,625,780 Value ($000) $9,172 Avg Close — Range —
Q3 2024
Shares 1,600,687 Value ($000) $7,749 Avg Close — Range —
Q2 2024
Shares 1,559,772 Value ($000) $7,613 Avg Close — Range —
Q1 2024
Shares 1,449,426 Value ($000) $19,251 Avg Close — Range —
Q4 2023
Shares 1,130,163 Value ($000) $15,756 Avg Close — Range —
Q3 2023
Shares 1,052,880 Value ($000) $13,963 Avg Close — Range —
Q2 2023
Shares 956,727 Value ($000) $17,939 Avg Close — Range —
Q1 2023
Shares 885,771 Value ($000) $12,773 Avg Close — Range —
Q4 2022
Shares 847,733 Value ($000) $16 Avg Close — Range —
Q3 2022
Shares 782,712 Value ($000) $26,886 Avg Close — Range —
Q2 2022
Shares 467,220 Value ($000) $7,139 Avg Close — Range —
Q1 2022
Shares 426,268 Value ($000) $9,727 Avg Close — Range —
Q4 2021
Shares 290,468 Value ($000) $10,709 Avg Close — Range —
Q3 2021
Shares 274,804 Value ($000) $12,915 Avg Close — Range —
Q2 2021
Shares 32,102 Value ($000) $1,934 Avg Close — Range —